 | • レポートコード：B-GIR08C0308 • 出版社/出版日：GlobalInfoResearch / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、抗生物質耐性の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、オキサゾリジノン、リポグリコペプチド、テトラサイクリン、セファロスポリン、併用療法、その他等に区分しました。抗生物質耐性の世界市場概観、企業動向、企業別抗生物質耐性シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・抗生物質耐性の市場概観 ・抗生物質耐性の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・抗生物質耐性の企業別販売動向、市場シェア、市場集中度、競争動向 ・抗生物質耐性の世界市場規模 ・抗生物質耐性の北米市場分析（アメリカ、カナダ、メキシコ等） ・抗生物質耐性のアメリカ市場規模推移 ・抗生物質耐性のカナダ市場規模推移 ・抗生物質耐性のメキシコ市場規模推移 ・抗生物質耐性のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・抗生物質耐性のドイツ市場規模推移 ・抗生物質耐性のイギリス市場規模推移 ・抗生物質耐性のロシア市場規模推移 ・抗生物質耐性のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・抗生物質耐性の日本市場規模推移 ・抗生物質耐性の中国市場規模推移 ・抗生物質耐性の韓国市場規模推移 ・抗生物質耐性のインド市場規模推移 ・抗生物質耐性の東南アジア市場規模推移 ・抗生物質耐性の南米市場分析（ブラジル、アルゼンチン等） ・抗生物質耐性の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・抗生物質耐性の種類別分析/販売量、売上、市場シェア（） ・抗生物質耐性の用途別分析/市場規模（オキサゾリジノン、リポグリコペプチド、テトラサイクリン、セファロスポリン、併用療法、その他） ・抗生物質耐性の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・抗生物質耐性の販売チャネル・代理店・貿易業者・ディーラー分析 |
Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.
Scope of the Report:
The worldwide market for Antibiotic Resistance is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Antibiotic Resistance in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Allergan
AmpliPhi Biosciences
BioVersys GmbH
Macrolide Pharmaceuticals
Melinta Therapeutics
Merck
Nabriva Therapeutics
Nemesis Bioscience
Phage Technologies S.A
Tetraphase Pharmaceuticals
The Medicines Company
TPfizer
Westway Health
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Urinary Tract Infection
Intra-Abdominal Infections
Blood Stream Infections
Clostridium Difficile Infections
Acute Bacterial Skin and Skin Structure Infections
Bacterial Pneumonia
Market Segment by Applications, can be divided into
Oxazolidinones
Lipoglycopeptides
Tetracyclines
Cephalosporins
Combination therapies
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibiotic Resistance product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antibiotic Resistance, with price, sales, revenue and global market share of Antibiotic Resistance in 2017 and 2018.
Chapter 3, the Antibiotic Resistance competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibiotic Resistance breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Antibiotic Resistance market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Antibiotic Resistance sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Antibiotic Resistance Introduction
1.2 Market Analysis by Type
1.2.1 Urinary Tract Infection
1.2.2 Intra-Abdominal Infections
1.2.3 Blood Stream Infections
1.2.4 Clostridium Difficile Infections
1.2.5 Acute Bacterial Skin and Skin Structure Infections
1.2.6 Bacterial Pneumonia
1.3 Market Analysis by Applications
1.3.1 Oxazolidinones
1.3.2 Lipoglycopeptides
1.3.3 Tetracyclines
1.3.4 Cephalosporins
1.3.5 Combination therapies
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Antibiotic Resistance Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 AmpliPhi Biosciences
2.2.1 Business Overview
2.2.2 Antibiotic Resistance Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 BioVersys GmbH
2.3.1 Business Overview
2.3.2 Antibiotic Resistance Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 BioVersys GmbH Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Macrolide Pharmaceuticals
2.4.1 Business Overview
2.4.2 Antibiotic Resistance Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Melinta Therapeutics
2.5.1 Business Overview
2.5.2 Antibiotic Resistance Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Merck
2.6.1 Business Overview
2.6.2 Antibiotic Resistance Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Nabriva Therapeutics
2.7.1 Business Overview
2.7.2 Antibiotic Resistance Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Nemesis Bioscience
2.8.1 Business Overview
2.8.2 Antibiotic Resistance Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Phage Technologies S.A
2.9.1 Business Overview
2.9.2 Antibiotic Resistance Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tetraphase Pharmaceuticals
2.10.1 Business Overview
2.10.2 Antibiotic Resistance Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 The Medicines Company
2.11.1 Business Overview
2.11.2 Antibiotic Resistance Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 The Medicines Company Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 TPfizer
2.12.1 Business Overview
2.12.2 Antibiotic Resistance Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 TPfizer Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Westway Health
2.13.1 Business Overview
2.13.2 Antibiotic Resistance Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Westway Health Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Antibiotic Resistance Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Antibiotic Resistance Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Antibiotic Resistance Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Antibiotic Resistance Manufacturer Market Share in 2018
3.3.2 Top 6 Antibiotic Resistance Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Antibiotic Resistance Market Analysis by Regions
4.1 Global Antibiotic Resistance Sales, Revenue and Market Share by Regions
4.1.1 Global Antibiotic Resistance Sales and Market Share by Regions (2014-2019)
4.1.2 Global Antibiotic Resistance Revenue and Market Share by Regions (2014-2019)
4.2 North America Antibiotic Resistance Sales and Growth Rate (2014-2019)
4.3 Europe Antibiotic Resistance Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Antibiotic Resistance Sales and Growth Rate (2014-2019)
4.5 South America Antibiotic Resistance Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Antibiotic Resistance Sales and Growth Rate (2014-2019)
5 North America Antibiotic Resistance by Country
5.1 North America Antibiotic Resistance Sales, Revenue and Market Share by Country
5.1.1 North America Antibiotic Resistance Sales and Market Share by Country (2014-2019)
5.1.2 North America Antibiotic Resistance Revenue and Market Share by Country (2014-2019)
5.2 United States Antibiotic Resistance Sales and Growth Rate (2014-2019)
5.3 Canada Antibiotic Resistance Sales and Growth Rate (2014-2019)
5.4 Mexico Antibiotic Resistance Sales and Growth Rate (2014-2019)
6 Europe Antibiotic Resistance by Country
6.1 Europe Antibiotic Resistance Sales, Revenue and Market Share by Country
6.1.1 Europe Antibiotic Resistance Sales and Market Share by Country (2014-2019)
6.1.2 Europe Antibiotic Resistance Revenue and Market Share by Country (2014-2019)
6.2 Germany Antibiotic Resistance Sales and Growth Rate (2014-2019)
6.3 UK Antibiotic Resistance Sales and Growth Rate (2014-2019)
6.4 France Antibiotic Resistance Sales and Growth Rate (2014-2019)
6.5 Russia Antibiotic Resistance Sales and Growth Rate (2014-2019)
6.6 Italy Antibiotic Resistance Sales and Growth Rate (2014-2019)
7 Asia-Pacific Antibiotic Resistance by Country
7.1 Asia-Pacific Antibiotic Resistance Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Antibiotic Resistance Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Antibiotic Resistance Revenue and Market Share by Country (2014-2019)
7.2 China Antibiotic Resistance Sales and Growth Rate (2014-2019)
7.3 Japan Antibiotic Resistance Sales and Growth Rate (2014-2019)
7.4 Korea Antibiotic Resistance Sales and Growth Rate (2014-2019)
7.5 India Antibiotic Resistance Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Antibiotic Resistance Sales and Growth Rate (2014-2019)
8 South America Antibiotic Resistance by Country
8.1 South America Antibiotic Resistance Sales, Revenue and Market Share by Country
8.1.1 South America Antibiotic Resistance Sales and Market Share by Country (2014-2019)
8.1.2 South America Antibiotic Resistance Revenue and Market Share by Country (2014-2019)
8.2 Brazil Antibiotic Resistance Sales and Growth Rate (2014-2019)
8.3 Argentina Antibiotic Resistance Sales and Growth Rate (2014-2019)
8.4 Colombia Antibiotic Resistance Sales and Growth Rate (2014-2019)
9 Middle East and Africa Antibiotic Resistance by Countries
9.1 Middle East and Africa Antibiotic Resistance Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Antibiotic Resistance Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Antibiotic Resistance Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Antibiotic Resistance Sales and Growth Rate (2014-2019)
9.3 Turkey Antibiotic Resistance Sales and Growth Rate (2014-2019)
9.4 Egypt Antibiotic Resistance Sales and Growth Rate (2014-2019)
9.5 Nigeria Antibiotic Resistance Sales and Growth Rate (2014-2019)
9.6 South Africa Antibiotic Resistance Sales and Growth Rate (2014-2019)
10 Global Antibiotic Resistance Market Segment by Type
10.1 Global Antibiotic Resistance Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Antibiotic Resistance Sales and Market Share by Type (2014-2019)
10.1.2 Global Antibiotic Resistance Revenue and Market Share by Type (2014-2019)
10.2 Urinary Tract Infection Sales Growth and Price
10.2.1 Global Urinary Tract Infection Sales Growth (2014-2019)
10.2.2 Global Urinary Tract Infection Price (2014-2019)
10.3 Intra-Abdominal Infections Sales Growth and Price
10.3.1 Global Intra-Abdominal Infections Sales Growth (2014-2019)
10.3.2 Global Intra-Abdominal Infections Price (2014-2019)
10.4 Blood Stream Infections Sales Growth and Price
10.4.1 Global Blood Stream Infections Sales Growth (2014-2019)
10.4.2 Global Blood Stream Infections Price (2014-2019)
10.5 Clostridium Difficile Infections Sales Growth and Price
10.5.1 Global Clostridium Difficile Infections Sales Growth (2014-2019)
10.5.2 Global Clostridium Difficile Infections Price (2014-2019)
10.6 Acute Bacterial Skin and Skin Structure Infections Sales Growth and Price
10.6.1 Global Acute Bacterial Skin and Skin Structure Infections Sales Growth (2014-2019)
10.6.2 Global Acute Bacterial Skin and Skin Structure Infections Price (2014-2019)
10.7 Bacterial Pneumonia Sales Growth and Price
10.7.1 Global Bacterial Pneumonia Sales Growth (2014-2019)
10.7.2 Global Bacterial Pneumonia Price (2014-2019)
11 Global Antibiotic Resistance Market Segment by Application
11.1 Global Antibiotic Resistance Sales Market Share by Application (2014-2019)
11.2 Oxazolidinones Sales Growth (2014-2019)
11.3 Lipoglycopeptides Sales Growth (2014-2019)
11.4 Tetracyclines Sales Growth (2014-2019)
11.5 Cephalosporins Sales Growth (2014-2019)
11.6 Combination therapies Sales Growth (2014-2019)
11.7 Other Sales Growth (2014-2019)
12 Antibiotic Resistance Market Forecast (2019-2024)
12.1 Global Antibiotic Resistance Sales, Revenue and Growth Rate (2019-2024)
12.2 Antibiotic Resistance Market Forecast by Regions (2019-2024)
12.2.1 North America Antibiotic Resistance Market Forecast (2019-2024)
12.2.2 Europe Antibiotic Resistance Market Forecast (2019-2024)
12.2.3 Asia-Pacific Antibiotic Resistance Market Forecast (2019-2024)
12.2.4 South America Antibiotic Resistance Market Forecast (2019-2024)
12.2.5 Middle East and Africa Antibiotic Resistance Market Forecast (2019-2024)
12.3 Antibiotic Resistance Market Forecast by Type (2019-2024)
12.3.1 Global Antibiotic Resistance Sales Forecast by Type (2019-2024)
12.3.2 Global Antibiotic Resistance Market Share Forecast by Type (2019-2024)
12.4 Antibiotic Resistance Market Forecast by Application (2019-2024)
12.4.1 Global Antibiotic Resistance Sales Forecast by Application (2019-2024)
12.4.2 Global Antibiotic Resistance Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Antibiotic Resistance Picture
Table Product Specifications of Antibiotic Resistance
Figure Global Sales Market Share of Antibiotic Resistance by Types in 2018
Table Antibiotic Resistance Types for Major Manufacturers
Figure Urinary Tract Infection Picture
Figure Intra-Abdominal Infections Picture
Figure Blood Stream Infections Picture
Figure Clostridium Difficile Infections Picture
Figure Acute Bacterial Skin and Skin Structure Infections Picture
Figure Bacterial Pneumonia Picture
Figure Antibiotic Resistance Sales Market Share by Applications in 2018
Figure Oxazolidinones Picture
Figure Lipoglycopeptides Picture
Figure Tetracyclines Picture
Figure Cephalosporins Picture
Figure Combination therapies Picture
Figure Other Picture
Figure United States Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure France Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure UK Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure China Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure India Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Antibiotic Resistance Revenue (Value) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Antibiotic Resistance Type and Applications
Table Allergan Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AmpliPhi Biosciences Basic Information, Manufacturing Base and Competitors
Table AmpliPhi Biosciences Antibiotic Resistance Type and Applications
Table AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table BioVersys GmbH Basic Information, Manufacturing Base and Competitors
Table BioVersys GmbH Antibiotic Resistance Type and Applications
Table BioVersys GmbH Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Macrolide Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Macrolide Pharmaceuticals Antibiotic Resistance Type and Applications
Table Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Melinta Therapeutics Basic Information, Manufacturing Base and Competitors
Table Melinta Therapeutics Antibiotic Resistance Type and Applications
Table Melinta Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Antibiotic Resistance Type and Applications
Table Merck Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nabriva Therapeutics Basic Information, Manufacturing Base and Competitors
Table Nabriva Therapeutics Antibiotic Resistance Type and Applications
Table Nabriva Therapeutics Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Nemesis Bioscience Basic Information, Manufacturing Base and Competitors
Table Nemesis Bioscience Antibiotic Resistance Type and Applications
Table Nemesis Bioscience Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Phage Technologies S.A Basic Information, Manufacturing Base and Competitors
Table Phage Technologies S.A Antibiotic Resistance Type and Applications
Table Phage Technologies S.A Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Tetraphase Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Tetraphase Pharmaceuticals Antibiotic Resistance Type and Applications
Table Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table The Medicines Company Basic Information, Manufacturing Base and Competitors
Table The Medicines Company Antibiotic Resistance Type and Applications
Table The Medicines Company Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table TPfizer Basic Information, Manufacturing Base and Competitors
Table TPfizer Antibiotic Resistance Type and Applications
Table TPfizer Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Westway Health Basic Information, Manufacturing Base and Competitors
Table Westway Health Antibiotic Resistance Type and Applications
Table Westway Health Antibiotic Resistance Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Antibiotic Resistance Sales by Manufacturer (2017-2018)
Figure Global Antibiotic Resistance Sales Market Share by Manufacturer in 2017
Figure Global Antibiotic Resistance Sales Market Share by Manufacturer in 2018
Table Global Antibiotic Resistance Revenue by Manufacturer (2017-2018)
Figure Global Antibiotic Resistance Revenue Market Share by Manufacturer in 2017
Figure Global Antibiotic Resistance Revenue Market Share by Manufacturer in 2018
Figure Top 3 Antibiotic Resistance Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Antibiotic Resistance Manufacturer (Revenue) Market Share in 2018
Figure Global Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Global Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table Global Antibiotic Resistance Sales by Regions (2014-2019)
Table Global Antibiotic Resistance Sales Market Share by Regions (2014-2019)
Table Global Antibiotic Resistance Revenue by Regions (2014-2019)
Figure Global Antibiotic Resistance Revenue Market Share by Regions (2014-2019)
Figure Global Antibiotic Resistance Revenue Market Share by Regions in 2018
Figure North America Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Europe Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure South America Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure North America Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table North America Antibiotic Resistance Sales by Countries (2014-2019)
Table North America Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Figure North America Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Figure North America Antibiotic Resistance Sales Market Share by Countries in 2018
Table North America Antibiotic Resistance Revenue by Countries (2014-2019)
Table North America Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure North America Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure North America Antibiotic Resistance Revenue Market Share by Countries in 2018
Figure United States Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Canada Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Mexico Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Europe Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table Europe Antibiotic Resistance Sales by Countries (2014-2019)
Table Europe Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Table Europe Antibiotic Resistance Revenue by Countries (2014-2019)
Figure Europe Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure Europe Antibiotic Resistance Revenue Market Share by Countries in 2018
Figure Germany Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure UK Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure France Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Russia Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Italy Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Antibiotic Resistance Sales by Countries (2014-2019)
Table Asia-Pacific Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Antibiotic Resistance Sales Market Share by Countries 2018
Table Asia-Pacific Antibiotic Resistance Revenue by Countries (2014-2019)
Figure Asia-Pacific Antibiotic Resistance Revenue Market Share by Countries 2018
Figure China Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Japan Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Korea Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure India Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Southeast Asia Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure South America Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table South America Antibiotic Resistance Sales by Countries (2014-2019)
Table South America Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Figure South America Antibiotic Resistance Sales Market Share by Countries in 2018
Table South America Antibiotic Resistance Revenue by Countries (2014-2019)
Table South America Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure South America Antibiotic Resistance Revenue Market Share by Countries in 2018
Figure Brazil Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Argentina Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Colombia Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Antibiotic Resistance Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Antibiotic Resistance Sales by Countries (2014-2019)
Table Middle East and Africa Antibiotic Resistance Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Antibiotic Resistance Sales Market Share by Countries in 2018
Table Middle East and Africa Antibiotic Resistance Revenue by Countries (2014-2019)
Table Middle East and Africa Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antibiotic Resistance Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Antibiotic Resistance Revenue Market Share by Countries in 2018
Figure Saudi Arabia Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure UAE Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Egypt Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure Nigeria Antibiotic Resistance Sales and Growth Rate (2014-2019)
Figure South Africa Antibiotic Resistance Sales and Growth Rate (2014-2019)
Table Global Antibiotic Resistance Sales by Type (2014-2019)
Table Global Antibiotic Resistance Sales Share by Type (2014-2019)
Table Global Antibiotic Resistance Revenue by Type (2014-2019)
Table Global Antibiotic Resistance Revenue Share by Type (2014-2019)
Figure Global Urinary Tract Infection Sales Growth (2014-2019)
Figure Global Urinary Tract Infection Price (2014-2019)
Figure Global Intra-Abdominal Infections Sales Growth (2014-2019)
Figure Global Intra-Abdominal Infections Price (2014-2019)
Figure Global Blood Stream Infections Sales Growth (2014-2019)
Figure Global Blood Stream Infections Price (2014-2019)
Figure Global Clostridium Difficile Infections Sales Growth (2014-2019)
Figure Global Clostridium Difficile Infections Price (2014-2019)
Figure Global Acute Bacterial Skin and Skin Structure Infections Sales Growth (2014-2019)
Figure Global Acute Bacterial Skin and Skin Structure Infections Price (2014-2019)
Figure Global Bacterial Pneumonia Sales Growth (2014-2019)
Figure Global Bacterial Pneumonia Price (2014-2019)
Table Global Antibiotic Resistance Sales by Application (2014-2019)
Table Global Antibiotic Resistance Sales Share by Application (2014-2019)
Figure Global Lipoglycopeptides Sales Growth (2014-2019)
Figure Global Tetracyclines Sales Growth (2014-2019)
Figure Global Cephalosporins Sales Growth (2014-2019)
Figure Global Combination therapies Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Antibiotic Resistance Sales, Revenue and Growth Rate (2019-2024)
Table Global Antibiotic Resistance Sales Forecast by Regions (2019-2024)
Table Global Antibiotic Resistance Market Share Forecast by Regions (2019-2024)
Figure North America Sales Antibiotic Resistance Market Forecast (2019-2024)
Figure Europe Sales Antibiotic Resistance Market Forecast (2019-2024)
Figure Asia-Pacific Sales Antibiotic Resistance Market Forecast (2019-2024)
Figure South America Sales Antibiotic Resistance Market Forecast (2019-2024)
Figure Middle East and Africa Sales Antibiotic Resistance Market Forecast (2019-2024)
Table Global Antibiotic Resistance Sales Forecast by Type (2019-2024)
Table Global Antibiotic Resistance Market Share Forecast by Type (2019-2024)
Table Global Antibiotic Resistance Sales Forecast by Application (2019-2024)
Table Global Antibiotic Resistance Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の髄膜炎菌感染症の治療市場：市場規模・現状・予測 Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.In 2018, the glo…- ライノウイルス感染症薬市場：世界及び中国市場分析・予測（～2024年） Rhinovirus Infections Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Rhinovirus Infections Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rhinovirus Infec…
- 類鼻疽菌感染症薬市場：世界及び中国市場分析・予測（～2024年） Burkholderia Pseudomallei Infections Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Burkholderia Pseudomallei Infections Drug industry with a focus on the Chinese market. The report provides key statistics on the market …
- 細菌性肺炎治療薬市場：世界及び中国市場分析・予測（～2024年） Bacterial Pneumonia Therapeutics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Bacterial Pneumonia Therapeutics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Bact…
- 世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.In 2018, the global Gram-positive Bacterial Infection Drugs market size was xx million US$ and it is expected to reach xx million US$ by …